Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma.
10.3904/kjim.2014.29.2.250
- Author:
Ha Young LEE
1
;
Kyung Hee LEE
;
Myung Soo HYUN
;
Min Kyoung KIM
;
Sung Ae KOH
;
Hee Soon CHO
Author Information
1. Division of Hematology and Oncology, Department of Internal Medicine, Cancer Center Dongnam Institute Radiological and Medical Sciences, Busan, Korea.
- Publication Type:Case Reports ; Letter ; Review
- Keywords:
Chronic myeloid leukemia;
Diffuse large B-cell lymphoma;
Therapy-related
- MeSH:
Adult;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use;
Benzamides/therapeutic use;
Bone Marrow Examination;
Chemoradiotherapy;
Cyclophosphamide/administration & dosage;
Doxorubicin/administration & dosage;
Humans;
Karyotyping;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*diagnosis/drug therapy/genetics/pathology;
Lymphoma, Large B-Cell, Diffuse/*diagnosis/pathology/therapy;
Male;
*Neoplasms, Second Primary;
Piperazines/therapeutic use;
Positron-Emission Tomography;
Prednisolone/administration & dosage;
Protein Kinase Inhibitors/therapeutic use;
Pyrimidines/therapeutic use;
Time Factors;
Tomography, X-Ray Computed;
Treatment Outcome;
Vincristine/administration & dosage;
Whole Body Imaging/methods
- From:The Korean Journal of Internal Medicine
2014;29(2):250-252
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
